Deafness: Clinical Trials

198 trials for Deafness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

82 completed, 39 recruiting, 24 unknown, 17 terminated. 88 Not applicable, 29 Phase 2, 15 Phase 1, 11 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable88Completed 37, Recruiting 15, Unknown 13, Not yet recruiting 7, Terminated 6, Withdrawn 4, Enrolling by invitation 3, Active not recruiting 2, Suspended 1
Phase 229Completed 12, Active not recruiting 4, Recruiting 4, Terminated 4, Unknown 3, Not yet recruiting 1, Withdrawn 1
Phase 115Completed 7, Recruiting 4, Unknown 2, Active not recruiting 1, Terminated 1
Phase 311Completed 3, Terminated 3, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Early Phase 11Completed 1
Phase 41Terminated 1

Follow Deafness: new trials by email Literature Review of Deafness trials Research Report on Deafness

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
N-acetylcysteine amide, Placebo - Retinitis Pigmentosa (RP), Usher Syndrome
Phase 3Not yet recruitingNacuity Pharmaceuticals, Inc.802026-12-012026-07-01
A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
Placebo, NPI-001 - Retinitis Pigmentosa (RP), Usher Syndrome
Phase 3RecruitingNacuity Pharmaceuticals, Inc.802026-10-232026-11-10
SENSE-Brain Health Pro for Older Adults With Sensory Loss
Brain Health Pro - Vision and Hearing Loss, Vision Impairment
Not applicableNot yet recruitingUniversité de Montréal3002026-10-152026-10-05
Study to Evaluate the Long-Term Safety of Ultevursen in Participants With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
No intervention, will not receive any active study intervention, Intravitreal Injection of Ultevursen - Retinitis Pigmentosa (RP), Usher Syndrome Type 2
Phase 2Not yet recruitingLaboratoires Thea812026-10-052026-09-01
Improving Cochlear Implant Outcomes Through Modeling and Programming Strategies Based on Human Inner Ear Pathology
Everyday Clinical Listening Program (Control), ENI-Based Experimental Program 1, ENI-Based Experimental Program 2 - Deafness
Not applicableRecruitingMassachusetts Eye and Ear Infirmary452026-10-012026-10-09
Retrospective Analysis of Performance and Safety of MED-EL Cochlear Implants.
Cochlear implantation - Severe to Profound Hearing Loss
Not yet recruitingMED-EL Elektromedizinische Geräte GesmbH7002026-10-012026-09-09
Cognitive Processing of Natural Sequences in Humans and Artificial Intelligence (AI)
Hearing Disorders and Deafness
Not yet recruitingInstitut Pasteur7002026-09-012026-07-31
Evaluation of the Effectiveness of a Rehabilitation Program for Hearing and Communication Disorders in Elderly People in Nursing Homes.
use of hearing rehabilitation device - Deafness
Not applicableNot yet recruitingUniversity Hospital, Toulouse402026-09-012026-05-19
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
SPI-1005 Low Dose, SPI-1005 Middle Dose, SPI-1005 High Dose - Lung Cancer, Head and Neck Cancer
Phase 2WithdrawnSound Pharmaceuticals, Incorporated2026-06-012026-06-03
Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss
SKY-GJB2 - GJB2-mediated Hearing Loss, GJB2 Gene Mutation
Phase 1 / Phase 2RecruitingSkylark Bio Inc.102026-05-282026-08-27
Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance
Transcorneal Electrical Stimulation using the OkuStim System - Retinitis Pigmentosa (RP), Usher Syndrome
RecruitingOkuvision GmbH302026-04-202026-05-01
Language Development in Children With Cochlear Implants and Speech-language Therapy Interventions
Speech-language therapy (observed standard care) - Severe to Profound Prelingual Hearing Loss
RecruitingAssistance Publique - Hôpitaux de Paris602026-04-172026-05-28
OSIA System Bilateral Implantation Efficacy Evaluation in Children With Ear Aplasia
Audiological tests, Speech, Spatial and Qualities of Hearing Scale - Deafness Caused by High Grade Microtia or Ear Atresia
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris122026-04-012026-02-13
ListenFuture-Listening for Their Future: Deaf and Hard-of-Hearing Adolescents
Hearing Disorders and Deafness
RecruitingHeikki Löppönen2562026-03-012026-02-25
Characterization and Contribution of Genome-wide DNA Methylation (DNA Methylation Episignatures) in Rare Diseases With Prenatal Onset
Methylation analysis - Rare Fetal Genetic Diseases, Congenital Malformation
RecruitingAssistance Publique - Hôpitaux de Paris632026-02-262026-03-27
Does Recessive Optic Atrophy Due to WFS1 Exist?
analyse study - Wolfram Syndrome 1, Optic Atrophies, Hereditary
Not yet recruitingHôpital Necker-Enfants Malades452026-02-012026-01-13
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
Ototoxic Hearing Loss, Ototoxicity, Drug-Induced
RecruitingSimon Jäger552026-01-202026-10-20
Extended Reality Vocational Training for Hearing Impaired
Interactive 360-degree Virtual Reality Vocational Training - Hearing Impairment, Deafness
Not applicableCompletedKing Salman Center for Disability Research482026-01-032026-06-10
Comparative Analysis of Hearing Outcomes: Robotic vs. Manual Insertion of Cochlear Implants
IotaSoft Robotic Insertion System, Manual Cochlear Implant Insertion - Sensorineural Hearing Loss, Bilateral Hearing Loss
Not applicableNot yet recruitingAdventHealth322026-01-012026-01-02
Mechanisms of Fecal Incontinence in Wolfram Syndrome
Retrospective case-control analysis - Wolfram Syndrome, Fecal Incontinence
Not yet recruitingHôpital Necker-Enfants Malades202025-12-202025-12-31

Showing 20 of 198. Sign in to see all of them.

Narrower conditions

Hearing Loss (65)  ·  Usher Syndromes (33)  ·  Retinitis Pigmentosa (27)  ·  Hearing Loss, Sensorineural (25)  ·  Hearing Disorders (17)  ·  Wolfram Syndrome (12)  ·  Ear Diseases (11)  ·  Diabetes Mellitus (10)  ·  Hearing Loss, Conductive (10)  ·  Retinal Diseases (10)  ·  Vision Disorders (8)  ·  Hearing Loss, Mixed Conductive-Sensorineural (7)  ·  Otorhinolaryngologic Diseases (7)  ·  Eye Diseases (6)

Broader conditions

Nervous System Diseases (196)  ·  Neurologic Manifestations (196)  ·  Sensation Disorders (195)  ·  Otorhinolaryngologic Diseases (191)  ·  Pathological Conditions, Signs and Symptoms (189)  ·  Ear Diseases (187)  ·  Signs and Symptoms (187)  ·  Hearing Disorders (181)  ·  Hearing Loss (133)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (61)  ·  Abnormalities, Multiple (58)  ·  Congenital Abnormalities (58)  ·  Eye Diseases (53)  ·  Genetic Diseases, Inborn (53)  ·  Blindness (52)

Interventions

Cochlear Implants (5)  ·  Acetylcysteine (4)  ·  Cochlear Implantation (4)  ·  Intravitreal Injections (4)  ·  Surveys and Questionnaires (3)  ·  Ankle Brachial Index (2)  ·  D-JNKI-1 (2)  ·  Educational Status (2)  ·  Genotype (2)  ·  Hearing Aids (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Speech Therapy (2)  ·  Telemedicine (2)  ·  Valproic Acid (2)  ·  ebselen (2)

Sponsors

Assistance Publique - Hôpitaux de Paris (9)  ·  University Hospital, Toulouse (9)  ·  Hospices Civils de Lyon (6)  ·  Laboratoires Thea (5)  ·  Massachusetts Eye and Ear Infirmary (5)  ·  National Institute on Deafness and Other Communication Disorders (NIDCD) (5)  ·  Cochlear (4)  ·  NYU Langone Health (4)  ·  Oticon Medical (4)  ·  Washington University School of Medicine (4)  ·  CHU de Reims (3)  ·  Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (3)  ·  Cochlear Bone Anchored Solutions (3)  ·  East Carolina University (3)  ·  Gallaudet University (3)

Countries

United States (81)  ·  France (48)  ·  Canada (17)  ·  Netherlands (14)  ·  Germany (12)  ·  United Kingdom (10)  ·  Australia (8)  ·  Italy (6)  ·  Switzerland (6)  ·  Denmark (5)  ·  Brazil (4)  ·  China (4)  ·  Spain (4)  ·  Austria (3)  ·  Hong Kong (3)

Top investigators

Thomas B Friedman, Ph.D. (3)  ·  Claire M Bernstein, PhD (2)  ·  Diane M Brewer, MA (2)  ·  Jonathan Kil, MD (2)  ·  Julie Arenberg (2)  ·  Michio Hirano, MD (2)  ·  Sarah Neuhaus, D.O. (2)  ·  Aaron J Newman, PhD (1)  ·  Aaron Newman, PhD (1)  ·  Amy Lieberman, PhD (1)  ·  Angelica Perez Fornos, PhD (1)

Results publications

PMID 37552281, PMID 10547481, PMID 10590970, PMID 14576249, PMID 15064663, PMID 1555319, PMID 15715067, PMID 15978485, PMID 16504089, PMID 17329129, PMID 2069187, PMID 21340183, PMID 23604349, PMID 24705452, PMID 24975234, PMID 25073872, PMID 25634465, PMID 25790770, PMID 26025012, PMID 26199618, PMID 26366332, PMID 26604914, PMID 26635571, PMID 26742931, PMID 27459537, PMID 27857759, PMID 27898605, PMID 27904503, PMID 28692981, PMID 28716314, PMID 29270420, PMID 29714549, PMID 29718280, PMID 29914727, PMID 30050918, PMID 30358468, PMID 30837546, PMID 31119146, PMID 31215818, PMID 31530099, PMID 31533581, PMID 31620478, PMID 32039263, PMID 32231088, PMID 32231633, PMID 32573764, PMID 32576247, PMID 32885711, PMID 33388985, PMID 33546345

NIH funding

2018 (2), 1UG1EY033293 (1), 2023 (1), P30DK111024 (1), R01DC010075 (1), R01DC015272 (1), R01DC016901 (1), R01DC016957 (1), R01DK132090 (1), R01HD070855 (1), R01HD117137 (1), R21DC019458 (1), R21DK113487 (1), R44DC013467 (1), U54NS078059 (1)